Tag: Ng Kay Ian
Fangda, Sullivan & Cromwell act on XPeng buy of Didi’s EV unit
Fangda Partners and Sullivan & Cromwell have advised Chinese electric vehicle maker XPeng on its HKD5.84 billion (USD744 million) acquisition of Didi Global
AIM Vaccine taps S&C and Jingtian on HKD156m listing on HKEX
China’s biggest privately owned vaccine group AIM Vaccine enlisted legal advice from Sullivan & Cromwell (S&C) and Jingtian & Gongcheng for its debut on the HKEX